Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) EBITDA Margin (2020 - 2024)

BioAtla (BCAB) has 2 years of EBITDA Margin data on record, last reported at 12184.0% in Q2 2021.

  • For Q2 2021, EBITDA Margin fell 980505.0% year-over-year to 12184.0%; the TTM value through Mar 2022 reached 40795.6%, down 2674060.0%, while the annual FY2024 figure was 672.21%, N/A changed from the prior year.
  • EBITDA Margin reached 12184.0% in Q2 2021 per BCAB's latest filing, down from 5343.33% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 1246.07% in Q1 2020 and bottomed at 12184.0% in Q2 2021.